Suvretta Capital Management, LLC Horizon Therapeutics Public LTD CO Transaction History

Suvretta Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$98.98 - $115.74 $697,017 - $815,041	-7,042 Reduced 0.89%	786,313 $91 Million
Q2 2023 Aug 14, 2023	SELL	$96.34 - $112.38 $17.4 Million - $20.3 Million	-180,400 Reduced 18.53%	793,355 $81.6 Million
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $10.7 Million - $11.3 Million	99,464 Added 11.38%	973,755 $106 Million
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $10.1 Million - $18.4 Million	161,730 Added 22.7%	874,291 $99.5 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $13.3 Million - $19.1 Million	225,900 Added 46.42%	712,561 $44.1 Million
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $38.6 Million - $56.6 Million	486,661 New	486,661 $38.8 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Suvretta Capital Management, LLC with notifications on news.